Overview

Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the drug-drug interaction potential of clarithromycin XL on Diltiazem hydrochloride (DTZ) 2% cream.
Phase:
Phase 1
Details
Lead Sponsor:
Ventrus Biosciences, Inc
Collaborator:
TKL Research, Inc.
Treatments:
Clarithromycin
Diltiazem